Jaguar Health (JAGX) Cash & Current Investments (2014 - 2026)

Jaguar Health (JAGX) has 13 years of Cash & Current Investments data on file, last reported at $10.1 million in Q1 2026.

• On a quarterly basis, Cash & Current Investments rose 76.87% year-over-year to $10.1 million in Q1 2026; TTM through Mar 2026 was $10.1 million, a 76.87% increase from a year earlier, with the FY2025 full-year figure at $7.8 million, down 2.12% from the prior year.
• Cash & Current Investments for Q1 2026 stood at $10.1 million, up from $7.8 million in the prior quarter.
• Over the last five years, Cash & Current Investments for JAGX reached as high as $17.5 million in Q1 2022 and fell as low as $2.2 million in Q2 2025.
• Historically, Cash & Current Investments has averaged $9.0 million across 5 years, with a median of $8.6 million in 2023.
• Across the five-year window, Cash & Current Investments surged 311.31% in 2024 and tumbled 86.25% in 2025, its largest moves.
• Year by year, Cash & Current Investments stood at $5.5 million in 2022, then grew by 18.28% to $6.5 million in 2023, then advanced by 23.7% to $8.0 million in 2024, then declined by 2.12% to $7.8 million in 2025, then grew by 28.5% to $10.1 million in 2026.
• Per Business Quant data, the three most recent Cash & Current Investments figures were $10.1 million in Q1 2026, $7.8 million in Q4 2025, and $3.5 million in Q3 2025.